Figure 1.
Elevated IRF8 causes aberrant myeloid differentiation potential of GATA2-deficient progenitor cells. (A) Experimental strategy for double mutant in vivo rescue system. Mice heterozygous for −77 enhancer deletion or Irf8tm1.2Hm were bred to generate E14.5 embryos. Fetal liver progenitor populations with select genotypes were analyzed by flow cytometry. (B) Representative flow cytometry analysis of progenitor populations from GMPs (Lin−Sca-1−cKit+CD34+CD16/32high). GPs and MPs are distinguished from multipotential GMPs by expression of Ly6C and from each other by M-CSFR (CD115). (C) Quantitation of the frequency of MPs and GPs within the Ly6C+ GMP populations from 7 litters (−77+/+Irf8+/+, n = 7; −77−/−Irf8+/+, n = 5; −77+/+Irf8−/−, n = 3: −77−/−Irf8+/−, n = 8; −77−/−Irf8−/−, n = 7). Relevant statistical comparisons for panel C are described in "Results." (D) Quantitation of colonies from sorted Ly6C− GMPs plated in M3434 methylcellulose media (STEMCELL Technologies) at 1200 cells/plate. Colonies were scored as mixed-lineage CFU-GM, or single-lineage granulocyte CFU-G, or CFU-M colonies. Ly6C− GMPs were obtained from 4 litters (−77+/+Irf8+/+, n = 6; −77−/−Irf8+/+, n = 8; −77+/+Irf8−/−, n = 6; −77−/−Irf8+/−, n = 5; −77−/−Irf8−/−, n = 6). Error bars for all plots represent mean ± standard error of the mean (SEM). *P < .05, **P < .01, ***P < .001, ****P < .0001; Welch’s unequal variance t tests.